Literature DB >> 21326720

Epidemiology of primary and secondary liver cancers.

Ashwin Ananthakrishnan1, Veena Gogineni, Kia Saeian.   

Abstract

Primary liver cancer is the sixth most common cancer worldwide with a wide geographic distribution. The incidence of primary liver cancer is increasing and there is still a higher prevalence in developing countries. Early recognition remains an obstacle and lack of it results in poor outcomes for hepatocellular carcinoma (HCC), the most prevalent primary liver cancer, and cholangiocarcinoma. The most common risk factors associated with HCC are hepatitis B and chronic hepatitis C infections, alcohol use, smoking, and aflatoxin exposure. Emerging risk factors such as obesity might play an important role in the future because of the increasing prevalence of this condition.

Entities:  

Keywords:  Primary liver cancer; cholangiocarcinoma; chronic hepatitis B; chronic hepatitis C; hepatocellular carcinoma

Year:  2006        PMID: 21326720      PMCID: PMC3036307          DOI: 10.1055/s-2006-939841

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  217 in total

1.  Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.

Authors:  Rachel E Bullock; Abed M Zaitoun; Guruprasad P Aithal; Stephen D Ryder; Ian J Beckingham; Dileep N Lobo
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

2.  Are alcohol, tobacco and obesity genuine risk factors for hepatocellular carcinoma?

Authors:  Teh-Ia Huo; Jaw-Ching Wu; Shou-Dong Lee
Journal:  J Hepatol       Date:  2005-04-02       Impact factor: 25.083

3.  Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Authors:  K M Boberg; A Bergquist; S Mitchell; A Pares; F Rosina; U Broomé; R Chapman; O Fausa; T Egeland; G Rocca; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

4.  Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.

Authors:  Shu-Yuan Chen; Li-Yu Wang; Ruth M Lunn; Wei-Yann Tsai; Po-Huang Lee; Chue-Shue Lee; Habibul Ahsan; Yu-Jing Zhang; Chien-Jen Chen; Regina M Santella
Journal:  Int J Cancer       Date:  2002-05-01       Impact factor: 7.396

5.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Authors:  Jian-Min Yuan; Sugantha Govindarajan; Kazuko Arakawa; Mimi C Yu
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

7.  Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.

Authors:  D Kornfeld; A Ekbom; T Ihre
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

8.  Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.

Authors:  Ragaa E Omer; Anneleen Kuijsten; Abdelgadir M Y Kadaru; Frans J Kok; Mohammed O Idris; Ibrahim M El Khidir; Pieter van 't Veer
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

9.  Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study.

Authors:  Michiyo Matsuo
Journal:  Kurume Med J       Date:  2003

10.  Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries.

Authors:  M Lesurtel; J M Regimbeau; O Farges; M Colombat; A Sauvanet; J Belghiti
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-09       Impact factor: 2.566

View more
  64 in total

1.  Toward knowledge-based liver surgery: holistic information processing for surgical decision support.

Authors:  K März; M Hafezi; T Weller; A Saffari; M Nolden; N Fard; A Majlesara; S Zelzer; M Maleshkova; M Volovyk; N Gharabaghi; M Wagner; G Emami; S Engelhardt; A Fetzer; H Kenngott; N Rezai; A Rettinger; R Studer; A Mehrabi; L Maier-Hein
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-04-07       Impact factor: 2.924

2.  A preventable cancer.

Authors:  Lucas Laursen
Journal:  Nature       Date:  2014-12-04       Impact factor: 49.962

3.  Non-Invasive Radiofrequency Field Treatment to Produce Hepatic Hyperthermia: Efficacy and Safety in Swine.

Authors:  Jason C Ho; Lam Nguyen; Justin J Law; Matthew J Ware; V Keshishian; N C Lara; Trac Nguyen; Steven A Curley; Stuart J Corr
Journal:  IEEE J Transl Eng Health Med       Date:  2017-04-03       Impact factor: 3.316

4.  Metachronous Hepatic Angiosarcoma Presenting as a Mimic of Recurrent Hepatocellular Carcinoma.

Authors:  Eric K C Lau; Bernette Tsai; Harry Morrison; Michael Deftos; Albert Y Lin
Journal:  J Gastrointest Cancer       Date:  2019-09

5.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

6.  Analysis of liver-directed therapies in U.S. cancer patients.

Authors:  O B Alese; S Kim; Z Chen; S S Ramalingam; T K Owonikoko; B F El-Rayes
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

Review 7.  Aberrant lipid metabolism as a therapeutic target in liver cancer.

Authors:  Evans D Pope; Erinmarie O Kimbrough; Lalitha Padmanabha Vemireddy; Phani Keerthi Surapaneni; John A Copland; Kabir Mody
Journal:  Expert Opin Ther Targets       Date:  2019-05-10       Impact factor: 6.902

8.  Diffuse reflectance spectroscopy of human liver tumor specimens - towards a tissue differentiating optical biopsy needle using light emitting diodes.

Authors:  Alina Keller; Piotr Bialecki; Torsten Johannes Wilhelm; Marcus Klaus Vetter
Journal:  Biomed Opt Express       Date:  2018-02-08       Impact factor: 3.732

Review 9.  Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.

Authors:  Andrew Kuei; Sammy Saab; Sung-Ki Cho; Stephen T Kee; Edward Wolfgang Lee
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 10.  Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes.

Authors:  Olga Golubnitschaja; Krishna Chander Sridhar
Journal:  Clin Exp Metastasis       Date:  2016-08-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.